Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma

• Tim M. Illidge,
• Elizabeth H. Phillips,
• Nicholas Counsell,
• Ruth Pettengell,
• Peter W.M. Johnson,
• Dominic J. Culligan,
• Bilyana Popova,
• Laura Clifton-Hadley,
• Andrew McMillan,
• Peter Hoskin,
• Sally F. Barrington,
• John Radford

Affiliations

Tim M. Illidge

Division of Cancer Sciences, University of Manchester, National Institutes of Health Research Biomedical Research Centre Manchester Cancer Research Centre, Manchester, United Kingdom; Christie NHS Foundation Trust, Manchester, United Kingdom; Tim M. Illidge, Division of Cancer Sciences, University of Manchester, National Institutes of Health Biomedical Research Centre Manchester Cancer Research Centre, Christie NHS Foundation Trust, Manchester M20 4BX, United Kingdom;

Elizabeth H. Phillips

Cancer Research UK and UCL Cancer Trials Centre, University College London, London, United Kingdom

Nicholas Counsell

Cancer Research UK and UCL Cancer Trials Centre, University College London, London, United Kingdom

Ruth Pettengell

Haemato-oncology, St George's, University of London, London, United Kingdom

Peter W.M. Johnson

Cancer Research UK Centre, University of Southampton, Southampton, United Kingdom

Dominic J. Culligan

Haematology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom

Bilyana Popova

Cancer Research UK and UCL Cancer Trials Centre, University College London, London, United Kingdom

Laura Clifton-Hadley

Cancer Research UK and UCL Cancer Trials Centre, University College London, London, United Kingdom

Andrew McMillan

Haematology, Nottingham City Hospitals NHS Trust, Nottingham, United Kingdom

Peter Hoskin

Division of Cancer Sciences, University of Manchester, National Institutes of Health Research Biomedical Research Centre Manchester Cancer Research Centre, Manchester, United Kingdom; Christie NHS Foundation Trust, Manchester, United Kingdom; Clinical Oncology, Mount Vernon Hospital, Middlesex, United Kingdom

Sally F. Barrington

King's College London and Guy's and St Thomas' PET Centre, School of Biomedical Engineering and Imaging Sciences, Kings College London, King's Health Partners, London, United Kingdom

John Radford

Division of Cancer Sciences, University of Manchester, National Institutes of Health Research Biomedical Research Centre Manchester Cancer Research Centre, Manchester, United Kingdom; Christie NHS Foundation Trust, Manchester, United Kingdom